Skip to content
Disclosery

SPHERA FUNDS MANAGEMENT LTD.

Follow

13F filer, CIK 1496201, TEL AVIV, Israel

SPHERA FUNDS MANAGEMENT LTD. reported $766,539,858 across 105 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 36.49% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001496201-26-000004

Period
2026-06-30
Reported value
$767M
Holdings
105
Top 10 weight
36.49%
New
27
Sold out
18

Part of the filer group SPHERA FUNDS MANAGEMENT LTD.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CYTKadded+180,170$15.3M
INSMnew+118,800$12.7M
TEVAadded+363,107$12.3M
BMRNadded+188,650$10.8M
RYTMnew+80,400$8.93M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CRISreduced-1,895,941-$19.8M
NVMIreduced-28,197-$15.3M
TSEMreduced-37,470-$9.77M
FOLDexited-603,377-$8.72M
CLBTexited-631,521-$8.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001496201-26-000004, largest first. % of portfolio is the value over $698,825,963, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,130,216 shares; 2024Q4: 1,569,181 shares; 2025Q1: 1,572,181 shares; 2025Q2: 1,620,990 shares; 2025Q3: 1,507,025 shares; 2025Q4: 1,123,525 shares; 2026Q1: 1,136,975 shares; 2026Q2: 1,500,082 shares 1,500,082$50.8M7.27%+363,107Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 272,472 shares; 2024Q4: 190,672 shares; 2025Q1: 465,526 shares; 2025Q2: 480,974 shares; 2025Q3: 219,910 shares; 2025Q4: 449,003 shares; 2026Q1: 1,339,971 shares; 2026Q2: 1,469,971 shares 1,469,971$39.7M5.68%+130,000Timeline
TSEMTOWER SEMICONDUCTOR LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 209,441 shares; 2024Q4: 166,149 shares; 2025Q1: 61,549 shares; 2025Q2: 264,722 shares; 2025Q3: 311,802 shares; 2025Q4: 122,513 shares; 2026Q1: 145,735 shares; 2026Q2: 108,265 shares 108,265$28.2M4.04%-37,470Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,034,846 shares; 2024Q4: 1,381,241 shares; 2025Q1: 1,663,974 shares; 2025Q2: 1,571,564 shares; 2025Q3: 387,716 shares; 2025Q4: 762,563 shares; 2026Q1: 724,563 shares; 2026Q2: 1,014,606 shares 1,014,606$22.2M3.17%+290,043Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 24,455 shares; 2024Q4: 22,738 shares; 2025Q1: 22,738 shares; 2025Q2: 82,738 shares; 2025Q3: 82,738 shares; 2025Q4: 94,738 shares; 2026Q1: 92,526 shares; 2026Q2: 96,626 shares 96,626$20.9M2.99%+4,100Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 195,349 shares; 2024Q4: 228,776 shares; 2025Q1: 267,385 shares; 2025Q2: 100,085 shares; 2025Q3: 352,558 shares; 2025Q4: 300,623 shares; 2026Q1: 809,333 shares; 2026Q2: 588,494 shares 588,494$19.6M2.81%-220,839Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 147,000 shares; 2026Q1: 139,900 shares; 2026Q2: 328,550 shares 328,550$18.8M2.69%+188,650Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 225,021 shares; 2024Q4: 153,021 shares; 2025Q1: 144,961 shares; 2025Q2: 326,718 shares; 2025Q3: 161,517 shares; 2025Q4: 91,717 shares; 2026Q1: 39,817 shares; 2026Q2: 219,987 shares 219,987$18.7M2.68%+180,170Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 842,644 shares; 2024Q4: 905,279 shares; 2025Q1: 366,608 shares; 2025Q2: 87,108 shares; 2025Q3: 40,746 shares; 2025Q4: 107,746 shares; 2026Q1: 245,246 shares; 2026Q2: 245,346 shares 245,346$18.3M2.61%+100Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 335,024 shares; 2025Q2: 143,693 shares; 2025Q3: 98,526 shares; 2025Q4: 378,500 shares; 2026Q1: 416,340 shares; 2026Q2: 459,340 shares 459,340$17.8M2.54%+43,000Timeline
NVMINOVA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 51,960 shares; 2024Q4: 68,146 shares; 2025Q1: 90,697 shares; 2025Q2: 75,836 shares; 2025Q3: 43,896 shares; 2025Q4: 47,846 shares; 2026Q1: 53,366 shares; 2026Q2: 25,169 shares 25,169$13.7M1.96%-28,197Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 118,800 shares 118,800$12.7M1.81%newTimeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 355,554 shares; 2025Q2: 356,453 shares; 2025Q3: 154,343 shares; 2025Q4: 71,843 shares; 2026Q1: 227,343 shares; 2026Q2: 417,564 shares 417,564$12.5M1.78%+190,221Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 62,530 shares; 2026Q2: 62,530 shares 62,530$11.9M1.7%0Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 409,515 shares; 2024Q4: 384,515 shares; 2025Q1: 304,515 shares; 2025Q2: 219,515 shares; 2025Q3: 219,515 shares; 2025Q4: 239,515 shares; 2026Q1: 269,515 shares; 2026Q2: 269,515 shares 269,515$11.5M1.65%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 933,225 shares; 2024Q4: 538,111 shares; 2025Q1: 527,222 shares; 2025Q2: 398,309 shares; 2025Q3: 370,376 shares; 2025Q4: 825,576 shares; 2026Q1: 987,090 shares; 2026Q2: 1,620,753 shares 1,620,753$10.7M1.53%+633,663Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,190 shares; 2024Q4: 13,190 shares; 2025Q1: 11,690 shares; 2025Q2: 11,540 shares; 2025Q3: 10,040 shares; 2025Q4: 9,040 shares; 2026Q1: 9,040 shares; 2026Q2: 8,040 shares 8,040$9.64M1.38%-1,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,300 shares; 2026Q1: 9,040 shares; 2026Q2: 17,419 shares 17,419$9.35M1.34%+8,379Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 799,957 shares; 2025Q3: 643,957 shares; 2025Q4: 598,534 shares; 2026Q1: 574,029 shares; 2026Q2: 499,029 shares 499,029$9.31M1.33%-75,000Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 252,539 shares; 2024Q4: 288,539 shares; 2025Q1: not reported; 2025Q2: 174,900 shares; 2025Q3: 148,900 shares; 2025Q4: 212,202 shares; 2026Q1: 256,202 shares; 2026Q2: 356,534 shares 356,534$9.02M1.29%+100,332Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 419,103 shares; 2024Q4: 474,103 shares; 2025Q1: 507,829 shares; 2025Q2: 419,540 shares; 2025Q3: 207,764 shares; 2025Q4: 239,764 shares; 2026Q1: 243,575 shares; 2026Q2: 240,868 shares 240,868$8.96M1.28%-2,707Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,400 shares 80,400$8.93M1.28%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 128,396 shares; 2024Q4: 273,213 shares; 2025Q1: 234,834 shares; 2025Q2: 394,693 shares; 2025Q3: 431,693 shares; 2025Q4: 1,004,378 shares; 2026Q1: 537,628 shares; 2026Q2: 752,983 shares 752,983$8.15M1.17%+215,355Timeline
LRCXLAM RESEARCH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 18,470 shares 18,470$8M1.15%newTimeline
AMATAPPLIED MATLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 18,000 shares; 2025Q2: 18,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 11,040 shares 11,040$7.98M1.14%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 544,563 shares; 2026Q1: 343,563 shares; 2026Q2: 254,250 shares 254,250$7.95M1.14%-89,313Timeline
NVSNOVARTIS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,000 shares; 2024Q4: 50,000 shares; 2025Q1: 50,000 shares; 2025Q2: 37,000 shares; 2025Q3: 37,000 shares; 2025Q4: 37,000 shares; 2026Q1: 37,000 shares; 2026Q2: 50,000 shares 50,000$7.83M1.12%+13,000Timeline
SOLAREDGE TECHNOLOGIES INCSOLAREDGE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,000,000 shares; 2025Q4: 4,000,000 shares; 2026Q1: 4,000,000 shares; 2026Q2: 4,000,000 shares 4,000,000$7.75M1.11%0
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 410,417 shares; 2026Q1: 321,917 shares; 2026Q2: 416,417 shares 416,417$7.67M1.1%+94,500Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 38,000 shares; 2024Q4: 34,256 shares; 2025Q1: 30,256 shares; 2025Q2: 25,256 shares; 2025Q3: 25,256 shares; 2025Q4: 25,256 shares; 2026Q1: 30,256 shares; 2026Q2: 30,256 shares 30,256$7.61M1.09%0Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 59,600 shares; 2024Q4: 59,600 shares; 2025Q1: 59,600 shares; 2025Q2: 48,600 shares; 2025Q3: 48,600 shares; 2025Q4: 48,600 shares; 2026Q1: 48,600 shares; 2026Q2: 58,600 shares 58,600$7.53M1.08%+10,000Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 69,831 shares; 2024Q4: 69,831 shares; 2025Q1: 52,831 shares; 2025Q2: 40,831 shares; 2025Q3: 40,831 shares; 2025Q4: 35,831 shares; 2026Q1: 28,831 shares; 2026Q2: 28,831 shares 28,831$7.32M1.05%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 196,408 shares 196,408$7.32M1.05%newTimeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 721,111 shares; 2024Q4: 921,111 shares; 2025Q1: 921,111 shares; 2025Q2: 583,105 shares; 2025Q3: 583,105 shares; 2025Q4: 861,105 shares; 2026Q1: 696,105 shares; 2026Q2: 720,057 shares 720,057$7.29M1.04%+23,952Timeline
NVCTNUVECTIS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 382,945 shares 382,945$7.04M1.01%newTimeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 90,000 shares; 2024Q4: 90,000 shares; 2025Q1: 90,000 shares; 2025Q2: 86,000 shares; 2025Q3: 86,000 shares; 2025Q4: 86,000 shares; 2026Q1: 186,000 shares; 2026Q2: 286,000 shares 286,000$6.89M0.99%+100,000Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 176,663 shares 176,663$6.43M0.92%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 52,097 shares; 2025Q1: 26,097 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 127,000 shares; 2026Q2: 105,000 shares 105,000$6.34M0.91%-22,000Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 181,970 shares; 2024Q4: 251,935 shares; 2025Q1: 241,935 shares; 2025Q2: 209,837 shares; 2025Q3: 434,837 shares; 2025Q4: 932,247 shares; 2026Q1: 419,247 shares; 2026Q2: 483,747 shares 483,747$6.31M0.9%+64,500Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 214,334 shares; 2026Q2: 230,834 shares 230,834$5.86M0.84%+16,500Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 78,080 shares; 2024Q4: 98,080 shares; 2025Q1: 118,080 shares; 2025Q2: 105,677 shares; 2025Q3: 105,677 shares; 2025Q4: 115,677 shares; 2026Q1: 120,677 shares; 2026Q2: 120,677 shares 120,677$5.79M0.83%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 111,743 shares; 2025Q2: 128,515 shares; 2025Q3: 166,765 shares; 2025Q4: 226,765 shares; 2026Q1: 153,265 shares; 2026Q2: 112,765 shares 112,765$5.72M0.82%-40,500Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 122,752 shares; 2026Q1: 558,339 shares; 2026Q2: 1,019,832 shares 1,019,832$5.44M0.78%+461,493Timeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 100,000 shares; 2024Q4: 130,000 shares; 2025Q1: 130,000 shares; 2025Q2: 122,000 shares; 2025Q3: 122,000 shares; 2025Q4: 122,000 shares; 2026Q1: 122,000 shares; 2026Q2: 102,000 shares 102,000$5.35M0.77%-20,000Timeline
FBRXFORTE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 495,109 shares; 2025Q3: 474,309 shares; 2025Q4: 185,869 shares; 2026Q1: 184,984 shares; 2026Q2: 249,693 shares 249,693$5.31M0.76%+64,709Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 243,035 shares; 2026Q1: 86,518 shares; 2026Q2: 213,671 shares 213,671$5.24M0.75%+127,153Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 166,866 shares; 2024Q4: 90,193 shares; 2025Q1: 78,193 shares; 2025Q2: 57,497 shares; 2025Q3: not reported; 2025Q4: 158,265 shares; 2026Q1: 94,265 shares; 2026Q2: 94,265 shares 94,265$5.18M0.74%0Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 489,207 shares; 2026Q2: 652,590 shares 652,590$5.07M0.73%+163,383Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,100 shares; 2026Q1: 1,733,471 shares; 2026Q2: 2,257,106 shares 2,257,106$4.72M0.68%+523,635Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,297,321 shares; 2024Q4: 2,551,619 shares; 2025Q1: 2,307,119 shares; 2025Q2: 1,959,610 shares; 2025Q3: 1,280,233 shares; 2025Q4: 2,132,131 shares; 2026Q1: 1,772,131 shares; 2026Q2: 1,191,187 shares 1,191,187$4.69M0.67%-580,944Timeline
VSTVISTRA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 29,450 shares 29,450$4.67M0.67%newTimeline
TLNTALEN ENERGY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 12,135 shares 12,135$4.66M0.67%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 563,107 shares; 2024Q4: 1,211,533 shares; 2025Q1: 1,284,151 shares; 2025Q2: 1,310,233 shares; 2025Q3: 1,350,333 shares; 2025Q4: 1,178,164 shares; 2026Q1: 739,164 shares; 2026Q2: 756,164 shares 756,164$4.66M0.67%+17,000Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 53,538 shares; 2026Q2: 63,538 shares 63,538$4.65M0.66%+10,000Timeline
CLOUGLOBAL X FDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 195,900 shares 195,900$4.45M0.64%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 56,504 shares; 2024Q4: 236,262 shares; 2025Q1: 329,262 shares; 2025Q2: 221,416 shares; 2025Q3: 426,518 shares; 2025Q4: 392,894 shares; 2026Q1: 160,594 shares; 2026Q2: 199,594 shares 199,594$4.43M0.63%+39,000Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 408,436 shares; 2026Q2: 233,836 shares 233,836$4.38M0.63%-174,600Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 232,294 shares 232,294$4.29M0.61%newTimeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,807 shares; 2026Q1: 325,591 shares; 2026Q2: 325,591 shares 325,591$4.28M0.61%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 837,889 shares; 2026Q1: 866,464 shares; 2026Q2: 422,051 shares 422,051$4.22M0.6%-444,413Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 52,500 shares; 2026Q1: 55,110 shares; 2026Q2: 22,400 shares 22,400$4.2M0.6%-32,710Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,329,012 shares 1,329,012$4.13M0.59%newTimeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 185,000 shares; 2026Q2: 245,000 shares 245,000$4.13M0.59%+60,000Timeline
MDWDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 185,270 shares; 2025Q4: 230,347 shares; 2026Q1: 273,192 shares; 2026Q2: 273,192 shares 273,192$4.02M0.57%0Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 620,000 shares; 2025Q1: 596,992 shares; 2025Q2: 376,649 shares; 2025Q3: 338,752 shares; 2025Q4: 567,616 shares; 2026Q1: 567,616 shares; 2026Q2: 545,816 shares 545,816$3.94M0.56%-21,800Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 408,166 shares; 2026Q1: 548,272 shares; 2026Q2: 638,272 shares 638,272$3.71M0.53%+90,000Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 500,491 shares; 2025Q1: 205,859 shares; 2025Q2: 183,094 shares; 2025Q3: 407,709 shares; 2025Q4: 407,709 shares; 2026Q1: 247,961 shares; 2026Q2: 244,961 shares 244,961$3.66M0.52%-3,000Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,622,828 shares; 2026Q2: 1,353,000 shares 1,353,000$3.64M0.52%-269,828Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 460,985 shares 460,985$3.51M0.5%newTimeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 220,000 shares; 2026Q2: 879,000 shares 879,000$3.3M0.47%+659,000Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,757,458 shares 1,757,458$3.27M0.47%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,800 shares 10,800$3.25M0.47%newTimeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 610,087 shares; 2024Q4: 610,087 shares; 2025Q1: 343,522 shares; 2025Q2: 235,522 shares; 2025Q3: 245,522 shares; 2025Q4: 295,522 shares; 2026Q1: 295,522 shares; 2026Q2: 295,039 shares 295,039$3.24M0.46%-483Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 175,500 shares; 2026Q1: 114,796 shares; 2026Q2: 81,796 shares 81,796$3.19M0.46%-33,000Timeline
ORAORMAT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 79,000 shares; 2025Q1: 84,000 shares; 2025Q2: 78,000 shares; 2025Q3: 29,000 shares; 2025Q4: not reported; 2026Q1: 68,250 shares; 2026Q2: 28,015 shares 28,015$3.05M0.44%-40,235Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 173,475 shares; 2026Q1: 173,475 shares; 2026Q2: 183,475 shares 183,475$3.01M0.43%+10,000Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 414,478 shares; 2024Q4: 455,604 shares; 2025Q1: 366,304 shares; 2025Q2: 196,635 shares; 2025Q3: 260,385 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 926,004 shares 926,004$2.82M0.4%newTimeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 270,000 shares 270,000$2.78M0.4%newTimeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 9,500 shares; 2025Q3: 9,500 shares; 2025Q4: 7,500 shares; 2026Q1: 7,500 shares; 2026Q2: 7,500 shares 7,500$2.72M0.39%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 133,323 shares; 2024Q4: 156,494 shares; 2025Q1: 99,784 shares; 2025Q2: 145,372 shares; 2025Q3: 91,155 shares; 2025Q4: not reported; 2026Q1: 594,000 shares; 2026Q2: 164,437 shares 164,437$2.45M0.35%-429,563Timeline
CEGCONSTELLATION ENERGY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 9,850 shares 9,850$2.45M0.35%newTimeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 163,307 shares; 2025Q3: 78,307 shares; 2025Q4: 343,678 shares; 2026Q1: 343,678 shares; 2026Q2: 632,632 shares 632,632$2.42M0.35%+288,954Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,166 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 190,111 shares; 2026Q1: 136,015 shares; 2026Q2: 120,200 shares 120,200$1.75M0.25%-15,815Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 420,000 shares; 2025Q3: 408,146 shares; 2025Q4: 368,146 shares; 2026Q1: not reported; 2026Q2: 250,000 shares 250,000$1.7M0.24%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 84,000 shares; 2025Q2: 95,931 shares; 2025Q3: 173,931 shares; 2025Q4: 41,000 shares; 2026Q1: 50,800 shares; 2026Q2: 28,600 shares 28,600$1.53M0.22%-22,200Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 358,000 shares; 2026Q2: 219,700 shares 219,700$1.52M0.22%-138,300Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 199,761 shares; 2025Q4: 339,761 shares; 2026Q1: 469,761 shares; 2026Q2: 427,554 shares 427,554$1.5M0.21%-42,207Timeline
ORGOORGANOGENESIS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 550,000 shares; 2026Q2: 550,000 shares 550,000$1.34M0.19%0Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 649,309 shares 649,309$1.32M0.19%newTimeline
CRISCURIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,994,937 shares; 2026Q2: 98,996 shares 98,996$1.03M0.15%-1,895,941Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 195,212 shares; 2026Q1: 280,786 shares; 2026Q2: 86,461 shares 86,461$600K0.09%-194,325Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 27,876 shares 27,876$561K0.08%newTimeline
SKYESKYE BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,563,522 shares; 2024Q4: 1,564,628 shares; 2025Q1: 1,476,353 shares; 2025Q2: 538,434 shares; 2025Q3: 478,928 shares; 2025Q4: 478,928 shares; 2026Q1: 678,928 shares; 2026Q2: 678,928 shares 678,928$471K0.07%0Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 398,486 shares 398,486$336K0.05%newTimeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 166,147 shares; 2026Q1: 78,234 shares; 2026Q2: 22,632 shares 22,632$301K0.04%-55,602Timeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 626,810 shares; 2024Q4: 626,810 shares; 2025Q1: 626,810 shares; 2025Q2: 626,810 shares; 2025Q3: 626,810 shares; 2025Q4: 626,810 shares; 2026Q1: 626,810 shares; 2026Q2: 626,810 shares 626,810$226K0.03%0Timeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 270,000 shares; 2024Q4: 270,000 shares; 2025Q1: 270,000 shares; 2025Q2: 270,000 shares; 2025Q3: 270,000 shares; 2025Q4: 270,000 shares; 2026Q1: 270,000 shares; 2026Q2: 270,000 shares 270,000$217K0.03%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
XBISPDR SERIES TRUST S&P BIOTECHput150,000$23.7M-50,000
BIIBBIOGEN INC Stockcall100,000$21.6Mnew
CYTKCYTOKINETICS INC COM NEWcall100,000$8.52M-159,300
PRAXPRAXIS PRECISION MEDICINES I COM NEWcall12,500$4.18Mnew
TLTISHARES TR 20 YR TR BD ETFcall47,000$4.06M0
ABVXABIVAX SA SPONSORED ADSput20,000$2.67Mnew
TENXTENAX THERAPEUTICS INC COM NEWcall127,600$1.86Mnew
ORICORIC PHARMACEUTICALS INC COMcall100,000$1.08Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FOLDAMICUS THERAPEUTIC603,377$8.72Mshares
CLBTCELLEBRITE DI LTD631,521$8.7Mshares
APLSAPELLIS PHARMACEUTICALS INC214,914$8.65Mshares
PANWPALO ALTO NETWORKS INC52,800$8.46Mshares
CAMTCAMTEK LTD53,020$8.04Mshares
SLNOSOLENO THERAPEUTICS INC216,281$7.24Mshares
AMZNAMAZON COM INC31,940$6.65Mshares
AAOIAPPLIED OPTOELECTRONICS INC73,400$6.21Mshares
ENPHENPHASE ENERGY INC142,419$5.38Mshares
ZIMZIM INTEGRATED SHIPPING SERV105,950$2.79Mshares
SEDGSOLAREDGE TECHNOLOGIES INC52,836$2.7Mshares
IBITISHARES BITCOIN TRUST ETF59,505$2.29Mshares
ASNDASCENDIS PHARMA A/S8,000$1.83Mshares
OLMAOLEMA PHARMACEUTICALS INC100,000$1.49Mcall
BMYBRISTOL-MYERS SQUIBB CO17,500$1.06Mshares
NICENICE LTD5,611$619Kshares
DTILPRECISION BIOSCIENCES INC40,000$220Kshares
FHTXFOGHORN THERAPEUTICS INC12,224$58.4Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001496201-26-000004 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001496201-26-000004 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001496201-26-000003 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001496201-26-000002 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001496201-25-000017 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001496201-25-000010 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001496201-25-000007 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001496201-25-000001 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001496201-24-000017 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001496201-24-000010 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001496201-24-000006 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR/A 0001496201-24-000005 Quarter ended 2023-12-312024-02-15acceptance time not in the bulk data set
13F-HR 0001496201-24-000002 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001496201-23-000012 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001496201-23-000007 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001496201-23-000006 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001496201-23-000003 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001496201-22-000008 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001496201-22-000007 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001496201-22-000004 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001496201-22-000003 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001496201-21-000007 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001496201-21-000004 Quarter ended 2021-06-302021-08-17acceptance time not in the bulk data set
13F-HR 0001178913-21-001758 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001178913-21-000561 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001178913-20-003104 Quarter ended 2020-09-302020-11-12acceptance time not in the bulk data set
13F-HR 0001178913-20-002378 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001178913-20-001462 Quarter ended 2020-03-312020-05-14acceptance time not in the bulk data set
13F-HR 0001178913-20-000447 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR 0001178913-19-002713 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001178913-19-002162 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR/A 0001178913-19-001740 Quarter ended 2019-03-312019-06-20acceptance time not in the bulk data set
13F-HR 0001178913-19-001480 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001178913-19-000472 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001178913-18-002945 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001178913-18-002380 Quarter ended 2018-06-302018-08-13acceptance time not in the bulk data set
13F-HR 0001178913-18-001571 Quarter ended 2018-03-312018-05-10acceptance time not in the bulk data set
13F-HR 0001178913-18-000471 Quarter ended 2017-12-312018-02-12acceptance time not in the bulk data set
13F-HR/A 0001178913-17-003260 Quarter ended 2017-09-302017-11-27acceptance time not in the bulk data set
13F-HR 0001178913-17-003094 Quarter ended 2017-09-302017-11-09acceptance time not in the bulk data set
13F-HR 0001178913-17-002344 Quarter ended 2017-06-302017-08-09acceptance time not in the bulk data set
13F-HR 0001178913-17-001405 Quarter ended 2017-03-312017-05-11acceptance time not in the bulk data set
13F-HR 0001178913-17-000411 Quarter ended 2016-12-312017-02-13acceptance time not in the bulk data set
13F-HR 0001178913-16-006879 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001178913-16-006167 Quarter ended 2016-06-302016-08-10acceptance time not in the bulk data set
13F-HR 0001178913-16-005416 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001178913-16-004256 Quarter ended 2015-12-312016-02-11acceptance time not in the bulk data set
13F-HR 0001178913-15-003433 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0001178913-15-002526 Quarter ended 2015-06-302015-08-06acceptance time not in the bulk data set
13F-HR 0001178913-15-001551 Quarter ended 2015-03-312015-05-11acceptance time not in the bulk data set
13F-HR 0001178913-15-000425 Quarter ended 2014-12-312015-02-12acceptance time not in the bulk data set
13F-HR/A 0001178913-14-003634 Quarter ended 2014-09-302014-11-20acceptance time not in the bulk data set
13F-HR 0001178913-14-003523 Quarter ended 2014-09-302014-11-13acceptance time not in the bulk data set
13F-HR/A 0001178913-14-002732 Quarter ended 2014-06-302014-08-20acceptance time not in the bulk data set
13F-HR 0001178913-14-002610 Quarter ended 2014-06-302014-08-11acceptance time not in the bulk data set
13F-HR 0001178913-14-001658 Quarter ended 2014-03-312014-05-14acceptance time not in the bulk data set
13F-HR 0001178913-14-000543 Quarter ended 2013-12-312014-02-13acceptance time not in the bulk data set